However, better DSS rates were observed in patients with low FUCA2 expression in GBM (p = 0.016), KICH (p = 0.021), LGG (p=0.016), LIHC (p =0.001), LUAD (p = 0.003), LUSC (p = 0.042), MESO (p = 0.014) and UVM (p = 0.008). Here, FUCA2 is linked to glioblastoma.